MR imaging of the prostate and adjacent anatomic structures before, during, and after ejaculation: Qualitative and quantitative evaluation

Radiology

Volumn 271, Issue 2, 2014, Pages 452-460

  Medved, Milica ^a   Sammet, Steffen ^a   Yousuf, Ambereen ^a   Oto, Aytekin ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANATOMICAL VARIATION; ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DYNAMICS; EJACULATION; ELECTRON SPIN RESONANCE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMAGE ANALYSIS; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE; PROSTATE SIZE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME ULTRASOUND SCANNER; SEMINAL VESICLE; WILCOXON SIGNED RANKS TEST;

ADULT; EJACULATION; HEALTHY VOLUNTEERS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; PROSTATE;

EID: 84899584449     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14131374     Document Type: Article

References (28)

1. Murphy JB, Lipshultz LI. Abnormalities of ejaculation. Urol Clin North Am 1987;14(3):583-596.
2. Witt MA, Grantmyre JE. Ejaculatory failure. World J Urol 1993;11(2):89-95.
3. Barazani Y, Stahl PJ, Nagler HM, Stember DS. Management of ejaculatory disorders in infertile men. Asian J Androl 2012;14(4):525-529.
4. Yoshida M, Kudoh J, Homma Y, Kawabe K. Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia. Clin Interv Aging 2011;6:161-172.
5. Schilit S, Benzeroual KE. Silodosin: a selective alpha1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia. Clin Ther 2009;31(11):2489-2502.
6. Hoffman RM, MacDonald R, Monga M, Wilt TJ. Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: a systematic review. BJU Int 2004;94(7):1031-1036.
7. Tubaro A, Vicentini C, Renzetti R, Miano L. Invasive and minimally invasive treatment modalities for lower urinary tract symptoms: what are the relevant differences in randomised controlled trials? Eur Urol 2000;38 (Suppl 1):7-17.
8. Ravery V. Transurethral microwave thermotherapy versus transurethral resection of prostate. Tech Urol 2000;6(4):267-270.
9. Choo R, Long J, Gray R, Morton G, Gardner S, Danjoux C. Prospective survey of sexual function among patients with clinically localized prostate cancer referred for definitive radiotherapy and the impact of radiotherapy on sexual function. Support Care Cancer 2010;18(6):715-722.
10. Huyghe E, Delannes M, Wagner F, et al. Ejaculatory function after permanent 125I prostate brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2009;74(1):126-132.
11. Sullivan JF, Stember DS, Deveci S, Akin-Olugbade Y, Mulhall JP. Ejaculation profiles of men following radiation therapy for prostate cancer. J Sex Med 2013;10(5): 1410-1416.
12. Chung E, Brock G. Sexual rehabilitation and cancer survivorship: a state of art review of current literature and management strategies in male sexual dysfunction among prostate cancer survivors. J Sex Med 2013;10(Suppl 1):102-111.
13. Walz J, Perrotte P, Gallina A, et al. Ejaculatory disorders may affect screening for prostate cancer. J Urol 2007;178(1):232- 237; discussion 237-238.
14. Turkbey B, Choyke PL. Multiparametric MRI and prostate cancer diagnosis and risk stratification. Curr Opin Urol 2012;22(4):310-315.
15. Yakar D, Debats OA, Bomers JG, et al. Predictive value of MRI in the localization, staging, volume estimation, assessment of aggressiveness, and guidance of radiotherapy and biopsies in prostate cancer. J Magn Reson Imaging 2012;35(1):20-31.
16. Türkbey B, Bernardo M, Merino MJ, Wood BJ, Pinto PA, Choyke PL. MRI of localized prostate cancer: coming of age in the PSA era. Diagn Interv Radiol 2012;18(1):34-45.
17. Choi YJ, Kim JK, Kim N, Kim KW, Choi EK, Cho KS. Functional MR imaging of prostate cancer. Radio Graphics 2007;27(1):63-75; discussion 75-77.
18. Wu LM, Xu JR, Ye YQ, Lu Q, Hu JN. The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis. AJR Am J Roentgenol 2012;199(1):103-110.
19. Keener TS, Winter TC, Berger R, et al. Prostate vascular flow: the effect of ejaculation as revealed on transrectal power Doppler sonography. AJR Am J Roentgenol 2000;175(4): 1169-1172.
20. Wang HZ, Riederer SJ, Lee JN. Optimizing the precision in T1 relaxation estimation using limited flip angles. Magn Reson Med 1987;5(5):399-416.
21. Fram EK, Herfkens RJ, Johnson GA, et al. Rapid calculation of T1 using variable flip angle gradient refocused imaging. Magn Reson Imaging 1987;5(3):201-208.
22. Homer J, Beevers MS. Driven-equilibrium single-pulse observation of T1 relaxation: a reevaluation of a rapid "new" method for determining NMR spin-lattice relaxation times. J Magn Reson 1985;63(2): 287-297.
23. Claus FG, Hricak H, Hattery RR. Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radio Graphics 2004;24(Suppl 1):S167-S180.
24. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL. Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists. Adv Anat Pathol 2006;13(1): 57-59.
25. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL; ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005;29(9):1228-1242.
26. Gil-Vernet JM Jr, Alvarez-Vijande R, Gil-Vernet A, Gil-Vernet JM. Ejaculation in men: a dynamic endorectal ultrasonographical study. Br J Urol 1994;73(4):442-448.
27. Lotti F, Corona G, Colpi GM, et al. Seminal vesicles ultrasound features in a cohort of infertility patients. Hum Reprod 2012;27(4): 974-982.
28. Tsao J, Kozerke S. MRI temporal acceleration techniques. J Magn Reson Imaging 2012;36(3):543-560.